How should promethazine (Phenergan) be prescribed for an adult outpatient needing treatment or prophylaxis of nausea/vomiting, motion sickness, or allergic symptoms?

Prescribing Promethazine (Phenergan) in the Outpatient Setting

For adult outpatients, prescribe promethazine 12.5-25 mg orally every 4-6 hours as needed for nausea/vomiting or allergic symptoms, with a maximum of 25 mg per dose; for motion sickness, give 25 mg orally 30-60 minutes before travel, repeated every 12 hours as needed. Avoid injectable formulations in outpatient settings due to serious safety concerns.

Route Selection: Oral is Strongly Preferred

The oral route should be the default for outpatient prescribing. The FDA label explicitly states that "continued therapy, if indicated, should be via the oral route as soon as existing circumstances permit" 1. Injectable promethazine carries significant risks including tissue necrosis, gangrene, and potential amputation with inadvertent perivascular extravasation or intra-arterial injection 2. Patient safety organizations including the Institute for Safe Medication Practices have advocated for removing injectable promethazine from both inpatient and outpatient settings 3.

Specific Dosing by Indication

Nausea and Vomiting

• Dose: 12.5-25 mg orally every 4-6 hours as needed
• Maximum frequency: Not more often than every 4 hours 1
• Duration of action: 4-6 hours 4
• Onset: Effects evident within 5 minutes IV, slightly longer orally 4

A study of outpatient surgical patients found promethazine suppositories (25 mg) highly effective for post-discharge nausea and vomiting, with 89% of patients using them and all reporting symptom improvement 5. For outpatients, oral tablets or suppositories (if oral route not tolerated) are appropriate alternatives.

Allergic Conditions

• Dose: 25 mg orally
• Repeat dosing: May repeat within 2 hours if necessary 1
• Maintenance: Adjust to smallest effective dose after initial treatment

Motion Sickness

• Prophylactic dose: 25 mg orally 30-60 minutes before travel
• Maintenance: 25 mg every 12 hours as needed during travel

Recent research confirms promethazine 25 mg is effective for motion sickness prevention, with subjects receiving promethazine reporting motion sickness in only 12.6% of exposures versus 51.8% in placebo groups 6. This supports its use for motion sickness prophylaxis in outpatients 7.

Critical Safety Considerations

Avoid Injectable Formulations in Outpatient Settings

The 2023 FDA labeling update emphasizes that deep intramuscular administration is the preferred route for injectable promethazine when parenteral administration is necessary 1. However, for outpatient prescribing, this creates practical barriers and safety concerns that make oral formulations far more appropriate.

Respiratory Depression Risk

• Contraindicated in children under 2 years of age 1
• Use lowest effective dose in all patients
• Avoid combining with other CNS depressants (benzodiazepines, opioids, alcohol) without dose reduction 4
• Promethazine can cause respiratory depression, particularly when combined with narcotics 4, 2

Other Adverse Effects to Counsel Patients About

• Sedation and drowsiness (common)
• Hypotension, dizziness
• Dry mouth, blurred vision
• Extrapyramidal effects (restlessness to oculogyric crises)
• Neuroleptic malignant syndrome (rare but serious) 4, 2

When to Consider Alternatives

For chemotherapy-induced nausea or severe refractory symptoms, promethazine is not first-line. Modern antiemetic guidelines recommend 5-HT3 receptor antagonists (ondansetron, granisetron) combined with dexamethasone and NK1 receptor antagonists for high-emetogenic chemotherapy 8. Promethazine serves as an adjunctive or breakthrough agent in these contexts 9, 10.

For vertigo associated with BPPV, do not prescribe promethazine routinely. Vestibular suppressants like promethazine are only appropriate for short-term management of severe vegetative symptoms (nausea/vomiting) and should not substitute for repositioning maneuvers 11.

Practical Prescribing Algorithm

1. Confirm indication: Nausea/vomiting, allergic symptoms, or motion sickness prophylaxis
2. Verify age: Must be ≥2 years old
3. Screen for contraindications:
   • Concurrent CNS depressants (adjust doses if prescribed together)
   • Respiratory compromise
   • Known hypersensitivity
4. Prescribe oral formulation:
   • Tablets: 12.5-25 mg every 4-6 hours PRN
   • Suppositories: 25 mg every 4-6 hours PRN (if oral not tolerated)
5. Counsel on:
   • Sedation risk (avoid driving/operating machinery)
   • Avoid alcohol
   • Take 30-60 minutes before travel for motion sickness
   • Seek care if excessive sedation, difficulty breathing, or involuntary movements occur

Cost and Accessibility Considerations

Promethazine remains an inexpensive option compared to newer antiemetics. The 1998 study noted it as "inexpensive and efficacious" for outpatient use 5. However, the availability of safer alternatives with comparable efficacy (particularly 5-HT3 antagonists for nausea/vomiting) should factor into prescribing decisions 12, 3.

Lower doses may be equally effective with less sedation: A 2015 study found promethazine 6.25 mg IV as effective as 12.5 mg for postoperative nausea/vomiting, with significantly less sedation 13. While this was an IV study, it suggests that starting with 12.5 mg orally rather than 25 mg may optimize the benefit-to-sedation ratio for some outpatients.